Market Snapshot

S&P Futures
4,398.50
Dow Futures
34,889.00
NASDAQ Futures
15,093.50

4.64$-0.95 -16.99%
Market open    15:44:11 pm   
From: To:

Stock Snapshot

5.59
Prev. Close
4.90
Open
35.87M
Market Cap
152330.00
Number of Shares
4.4800
Day Low
5.1000
Day High
4.64
-
P/E Ratio
7.24M
Free Float in %
-13.35
EPS 2021
107.68
Book Value per Share
5.69
Cash Flow per Share
InspireMD, Inc. (NSPR)
InspireMD, Inc. (NSPR) stock rallied over -16.99% intraday to trade at $4.64 per share on NASDAQ. The stock opened with a fall of -12.34% at $4.90 and touched an intraday high of $5.1000, declining 8.77% against the last close of $5.59. The stock went to a low of $4.4800 during the session.

Historical Prices

DateOpenCloseAdj. CloseDaily HighDaily LowVolume
2021-06-30$5.02$5.05$5.05$5.10$5.0085,271
2021-06-29$5.28$5.12$5.12$5.28$5.02154,200
2021-06-28$5.46$5.28$5.28$5.50$5.23105,900
2021-06-25$5.27$5.46$5.46$5.50$5.26123,800
2021-06-24$5.25$5.27$5.27$5.31$5.2074,500
2021-06-23$5.12$5.21$5.21$5.26$5.08103,900
2021-06-22$5.08$5.16$5.16$5.19$4.92285,100
2021-06-21$5.11$4.86$4.86$5.14$4.81305,300
2021-06-18$5.20$5.15$5.15$5.33$5.00129,100
2021-06-17$5.42$5.24$5.24$5.50$5.2471,500
2021-06-16$5.66$5.40$5.40$5.84$5.27192,100
InspireMD, Inc.
4 Menorat Hamaor Street
Tel Aviv 6744832
Israel

http://www.inspiremd.com
972 3 6917691
Employees
45
Sector
Healthcare
Sales or Revenue
Industry
Medical Devices
5Y Sales Change
1.50
Fiscal Year Ends
2020-12-30
Mr. Marvin L. Slosman
Pres, CEO & Director
Mr. Craig Shore
CFO, Chief Admin. Officer, Sec. & Treasurer
Mr. Roei Samuri
VP of Operations
InspireMD, Inc.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms. The company sells its products through local distributors. InspireMD, Inc. is headquartered in Tel Aviv, Israel.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam